Copyright
©The Author(s) 2019.
World J Gastroenterol. Mar 21, 2019; 25(11): 1366-1377
Published online Mar 21, 2019. doi: 10.3748/wjg.v25.i11.1366
Published online Mar 21, 2019. doi: 10.3748/wjg.v25.i11.1366
Table 1 Comparison of demographic and laboratory data in F0, early fibrosis, and late fibrosis groups
Parameter | Control, n = 82 | Early fibrosis, n = 112 | Late fibrosis, n = 96 | P value |
Age | 38.3 ± 10.2 | 34.1 ± 8.9 | 41.4 ± 7.823 | 0.001 |
Gender (M:F) | 47:35 | 69:43 | 60:36 | 0.8 |
ALT | 36.29 ± 17.24 | 52.00 ± 36.071 | 57.17 ± 36.8823 | 0.001 |
AST | 35.00 ± 15.71 | 49.00 ± 25.121 | 58.00 ± 35.1223 | 0.001 |
Albumin | 4.10 ± 0.45 | 4.20 ± 0.44 | 3.80 ± 0.6923 | 0.001 |
Bilirubin | 0.88 ± 0.48 | 0.81 ± 0.26 | 1.02 ± 0.462 | 0.001 |
PCR | 95746 ± 10111 | 391000 ± 2138761 | 254500 ± 12931423 | 0.001 |
AFP | 7.50 ± 1.57 | 5.01 ± 2.951 | 10.47 ± 6.7823 | 0.001 |
Table 2 The median apparent diffusion coefficient and micro-RNAs values of patients versus controls
Parameter | Fibrosis, n = 208 | Control, n = 82 | P value |
ADC | 1.43 ± 0.22 | 1.92 ± 0.08 | 0.001 |
miR-200b | 4.61 ± 1.21 | 1.20 ± 0.81 | 0.001 |
miR-21 | 2.70 ± 1.30 | 1.29 ± 0.40 | 0.001 |
miR-29b | 0.58 ± 0.26 | 0.98 ± 0.16 | 0.001 |
Table 3 The receiver operating characteristic curve results with cut-off values of apparent diffusion coefficient and serum markers for patients and controls
Parameter | AUC | Cut-off point | Sensitivity | Specificity | Accuracy |
ADC | 0.992 | 1.825 | 98.6% | 97.0% | 97.1% |
miR-200b | 0.925 | 1.65 | 92.3% | 82.2% | 91.2% |
miR-21 | 0.865 | 1.35 | 82.2% | 76.0% | 84.2% |
miR-29b | 0.937 | 0.91 | 92.3% | 81.7% | 91.0% |
ADC and miR-200b | 0.995 | - | 100% | 96.0% | 96.9% |
ADC and miR-21 | 0.992 | - | 100% | 95.0% | 96.2% |
ADC and miR-29b | 0.992 | - | 100% | 95.9% | 95.9% |
Table 4 The median, minimum, and maximum values of apparent diffusion coefficient and serum markers of patients with early and late fibrosis
Variables | Early fibrosis, n = 112 | Late fibrosis, n = 96 | P value |
ADC | 1.5 ± 0.2 (1-1.9) | 1.25 ± 0.17 (0.9-1.5) | 0.001 |
miR-200b | 3.43 ± 1.71 (1.0-1.4) | 10.17 ± 4.81 (1-28.4) | 0.001 |
miR-21 | 1.9 ± 0.7 (1.0-4.2) | 3.6 ± 1.17 (1.0-6.34) | 0.001 |
miR-29b | 0.7 ± 0.12 (0.12-1.00) | 0.4 ± 0.2 (0.07-1.00) | 0.001 |
Table 5 The cut-off values of apparent diffusion coefficient and micro-RNAs used to differentiate early from late fibrosis with areas under the receiver operating characteristic curves, sensitivity, specificity and accuracy
Parameter | AUC | Cut-off point | Sensitivity | Specificity | Accuracy |
ADC | 0.866 | 1.53 | 99.0% | 67.0% | 81.7% |
miR-200b | 0.888 | 3.55 | 90.6% | 59.5% | 73.5% |
miR-21 | 0.877 | 2.38 | 91.7% | 70.3% | 80.2% |
miR-29b | 0.832 | 0.70 | 87.5% | 60.7% | 73% |
ADC and miR-200b | 0.925 | - | 71.7% | 97.2% | 80.2% |
ADC and miR-21 | 0.88 | - | 72.3% | 97.5% | 83.2% |
ADC and miR-29b | 0.879 | - | 74% | 96.5% | 85.1% |
- Citation: Besheer T, Elalfy H, Abd El-Maksoud M, Abd El-Razek A, Taman S, Zalata K, Elkashef W, Zaghloul H, Elshahawy H, Raafat D, Elemshaty W, Elsayed E, El-Gilany AH, El-Bendary M. Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus. World J Gastroenterol 2019; 25(11): 1366-1377
- URL: https://www.wjgnet.com/1007-9327/full/v25/i11/1366.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i11.1366